Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab PK with Methotrexate in Ulcerative Colitis
NCT01716039Phase 2Terminated
- Sponsor
- Alimentiv Inc.
- Start
- Jun 2013
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of methotrexate in ulcerative colitis (UC), sponsored by Alimentiv Inc.. Started Jun 2013; status: terminated.
02
Drugs
methotrexate
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01716039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716039.